RVPH EPS Estimates
Reviva Pharmaceuticals Holdings, Inc.
$0.48
+$0.00(+0.38%)
17
Overall
--
Value
20
Tech
15
Quality
Market Cap
$6.49M
Volume
91.25K
52W Range
$0.26 - $15.40
Target Price
$17.50
RVPH EPS estimates: the consensus estimate for Reviva Pharmaceuticals Holdings, Inc.'s current fiscal year is -$1.41 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
RVPH EPS Estimates
- EPS estimate, current quarter
- $-0.40
- EPS estimate, next quarter
- $-0.41
- EPS estimate, current year
- $-1.41
- EPS estimate, next year
- $-1.44
- EPS growth, 3-year
- +39.71%
| Fiscal year | EPS |
|---|---|
| 2025 | $-5.48 |
| 2024 | $-18.00 |
| 2023 | $-33.00 |
| 2022 | $-25.00 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RVPH | $0.48 | +0.4% | 91.25K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Reviva Pharmaceuticals Holdings, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW